The significance of CDT1 expression in non-cancerous and cancerous liver in cases with hepatocellular carcinoma
Copyright © 2023 JCBN..
We previously reported that chromatin licensing and DNA replication factor 1 (CDT1) expression was associated with the extent of proliferation of atypical hepatocytes and the time to postoperative recurrence in cases of hepatocellular carcinoma (HCC). This study aimed to clarify the clinical significance or pathogenesis of CDT1 expression in both non-cancerous and cancerous liver in HCC cases, including previously published data. We investigated the association between the expression of CDT1 in non-cancerous or cancerous liver tissues and histologic findings or biochemical examination results in 62 cases. We also examined the dual localization between CDT1 and FbxW7, P57kip2, P53 and c-Myc by confocal laser scanning microscopy. CDT1 mRNA expression was significantly higher in cancerous liver than in non-cancerous liver (p<0.0001). Elevated CDT1 mRNA expression indicates a significantly degree of inflammatory cell infiltration within lobules, along with elevated serum transaminase levels, and hepatic spare decline. CDT1 mRNA was highly expressed in a group of poorly differentiated cancer cells. CDT1 co-localized with P57kip2, Fbwx7, P53 and c-Myc in the nucleus or cytoplasm of hepatocytes and cancer cells. We found that CDT1 mRNA expression could represent the degree of hepatic spare ability and the high carcinogenic state.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
Journal of clinical biochemistry and nutrition - 73(2023), 3 vom: 23. Nov., Seite 234-248 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ogawa, Masahiro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chromatin licensing and DNA replication factor 1 |
|---|
| Anmerkungen: |
Date Revised 17.11.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3164/jcbn.23-43 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364621354 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364621354 | ||
| 003 | DE-627 | ||
| 005 | 20231226095819.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3164/jcbn.23-43 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1215.xml |
| 035 | |a (DE-627)NLM364621354 | ||
| 035 | |a (NLM)37970553 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ogawa, Masahiro |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The significance of CDT1 expression in non-cancerous and cancerous liver in cases with hepatocellular carcinoma |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2023 JCBN. | ||
| 520 | |a We previously reported that chromatin licensing and DNA replication factor 1 (CDT1) expression was associated with the extent of proliferation of atypical hepatocytes and the time to postoperative recurrence in cases of hepatocellular carcinoma (HCC). This study aimed to clarify the clinical significance or pathogenesis of CDT1 expression in both non-cancerous and cancerous liver in HCC cases, including previously published data. We investigated the association between the expression of CDT1 in non-cancerous or cancerous liver tissues and histologic findings or biochemical examination results in 62 cases. We also examined the dual localization between CDT1 and FbxW7, P57kip2, P53 and c-Myc by confocal laser scanning microscopy. CDT1 mRNA expression was significantly higher in cancerous liver than in non-cancerous liver (p<0.0001). Elevated CDT1 mRNA expression indicates a significantly degree of inflammatory cell infiltration within lobules, along with elevated serum transaminase levels, and hepatic spare decline. CDT1 mRNA was highly expressed in a group of poorly differentiated cancer cells. CDT1 co-localized with P57kip2, Fbwx7, P53 and c-Myc in the nucleus or cytoplasm of hepatocytes and cancer cells. We found that CDT1 mRNA expression could represent the degree of hepatic spare ability and the high carcinogenic state | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Ki-67 | |
| 650 | 4 | |a P57 kip2 | |
| 650 | 4 | |a chromatin licensing and DNA replication factor 1 | |
| 650 | 4 | |a hepatocellular carcinoma | |
| 650 | 4 | |a proliferation of atypical hepatocytes | |
| 700 | 1 | |a Moriyama, Mitsuhiko |e verfasserin |4 aut | |
| 700 | 1 | |a Midorikawa, Yutaka |e verfasserin |4 aut | |
| 700 | 1 | |a Nakamura, Hitomi |e verfasserin |4 aut | |
| 700 | 1 | |a Shibata, Toshikatu |e verfasserin |4 aut | |
| 700 | 1 | |a Kuroda, Kazumichi |e verfasserin |4 aut | |
| 700 | 1 | |a Nakayama, Hisashi |e verfasserin |4 aut | |
| 700 | 1 | |a Kanemaru, Kazunori |e verfasserin |4 aut | |
| 700 | 1 | |a Miki, Toshio |e verfasserin |4 aut | |
| 700 | 1 | |a Sugitani, Masahiko |e verfasserin |4 aut | |
| 700 | 1 | |a Takayama, Tadatoshi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical biochemistry and nutrition |d 1993 |g 73(2023), 3 vom: 23. Nov., Seite 234-248 |w (DE-627)NLM086732099 |x 0912-0009 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2023 |g number:3 |g day:23 |g month:11 |g pages:234-248 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3164/jcbn.23-43 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2023 |e 3 |b 23 |c 11 |h 234-248 | ||